Conditions: Acute T Cell Lymphoblastic Leukemia; Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Refractory; Acute Myeloid Leukemia (AML); T Cell Lymphoma
Interventions: Drug: HY035 cell injection
Sponsors: Institute of Hematology & Blood Diseases Hospital, China; Juventas Cell Therapy Ltd.
Enrolling by invitation Conditions: Acute T Cell Lymphoblastic Leukemia; Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Refractory; Acute Myeloid Leukemia (AML); T Cell Lymphoma
Interventions: Drug: HY035 cell injection
Sponsors: Institute of Hematology & Blood Diseases Hospital, China; Juventas Cell Therapy Ltd.
Enrolling by invitation
